IP Library Granted Patent US 9,649,220
Granted Patent B2
US 9,649,220 · App. 13/896,637 · Granted May 16, 2017

Treatment systems for removing heat from subcutaneous lipid-rich cells

Inventors: Richard Rox Anderson (Boston, MA); Dieter Manstein (Boston, MA)
Assignee: The General Hospital Corporation
A61F7/00A61B5/415A61B5/6804A61B18/02A61F7/10A61H23/00A61B2018/0237A61B2018/0262A61F2007/0054A61F2007/0056A61F2007/0075A61F2007/0082A61F2007/0094A61F2007/0096A61F2007/029A61F2007/0239
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,649,220
App. No.
13/896,637
Granted
May 16, 2017
Kind
B2
Abstract

The present invention relates to methods for use in the selective disruption of lipid-rich cells by controlled cooling. The present invention further relates to a device for use in carrying out the methods for selective disruption of lipid-rich cells by controlled cooling.

Claims (18)

1. A treatment system for removing heat from subcutaneous lipid-rich cells in a target region of a subject, comprising:

a treatment unit configured to produce an energy field in the subject's tissue and including a cooling/heating element configured to reduce a temperature of the target region such that the subcutaneous lipid-rich cells are damaged while nonlipid-rich cells of the subject are generally not injured; and

a feedback mechanism configured to monitor crystal formation in the subcutaneous lipid-rich cells.

2. The treatment system of claim 1 wherein the feedback mechanism is operable to provide at least one of ultrasound imaging, acoustical measurements, optical measurements, and mechanical measurements.

3. The treatment system of claim 1 , further

a control unit programmed to control operation of the treatment unit to output energy localized to at least one of the subject's dermis and epidermis and to reduce a temperature of the target region such that the subcutaneous lipid-rich cells are disrupted while non-lipid-rich cells of the subject are generally not injured.

4. The treatment system of claim 3 wherein the control unit is further programmed to control operation of the treatment unit to produce at least one of a substantially constant electric field or a substantially constant acoustic field.

5. The treatment system of claim 3 wherein the control unit is further programmed to control operation of the treatment unit to produce at least one of an oscillating electric field or an oscillating acoustic field.

6. The treatment system of claim 3 , further comprising:

a detector in communication with the control unit, wherein the control unit is further programmed to control operation of the treatment system based on temperature information from the detector.

7. The treatment system of claim 3 wherein the treatment unit includes an energy output element configured to output the energy.

8. The treatment system of claim 7 wherein the control unit is further programmed to control operation of the treatment unit to output the energy to tissue that has been cooled by the cooling/heating element.

9. The treatment system of claim 3 wherein the treatment unit outputs electrical energy.

10. The treatment system of claim 3 wherein the treatment unit outputs acoustic energy.

11. The treatment system of claim 3 , wherein the feedback mechanism monitors optical properties, electrical properties, and/or acoustic properties of the subject's tissue.

12. The treatment system of claim 3 , wherein the feedback mechanism is configured to output temperature information used to control operation of the treatment unit.

13. The treatment system of claim 3 wherein the control unit is further programmed to control operation of the treatment unit to perform a combination of cooling cycles and heating cycles.

14. The treatment system of claim 3 wherein the control unit is further programmed to control operation of the treatment unit to heat the target region after reducing the temperature of the subcutaneous lipid-rich cells.

Continuity (4)
Division 11434478 · May 15, 2006
Division 10391221 · Mar 17, 2003
Provisional Application 60365662 · Mar 15, 2002
Related Publication 20130253496A1 · Sep 26, 2013